I'd assume they're writing up an announcement to outline the results and discuss what the next steps are, and what this could mean for the company (potential market, maybe even some details about the partnership).
Would be nice anyway, who knows, exciting times. Lots of potential if this works for other endocrine transplants, and it just further validates the safety and efficacy of the matrix itself.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.035(2.64%) |
Mkt cap ! $891.1M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.35 | $1.29 | $2.596M | 1.984M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 66524 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 11567 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PNV (ASX) Chart |